Legal Opinion

In Re Cardizem CD Antitrust Litigation

District Court, E.D. Michigan

Decided May 11, 2000No. 99-md-1278PublishedCited by 67 opinions

1Opinion of the Court

ORDER NO. 12

MEMORANDUM OPINION AND ORDER DENYING DEFENDANTS’ MOTIONS TO DISMISS

EDMUNDS, District Judge.

Defendant Hoechst Marion Roussel, Inc. (“HMRI”), a wholly owned subsidiary of Defendant Hoechst Aktiengesellschaft (“Hoechst AG”), is the manufacturer of the brand name prescription heart drug Car-dizem CD which consists of a once-daily dosage of the chemical compound diltiazem hydrochloride. Cardizem CD is widely prescribed for the treatment of chronic chest pains (angina), high blood pressure (hypertension), and for the prevention of heart attacks and strokes. Until June 23, 1999, when…

2Cases cited116 opinions

  1. Conley v. GibsonSupreme Court of the United States · 1957
  2. International Shoe Co. v. WashingtonSupreme Court of the United States · 1945
  3. Insurance Corp. of Ireland v. Compagnie Des Bauxites De GuineeSupreme Court of the United States · 1982
  4. Associated General Contractors of California, Inc. v. California State Council of CarpentersSupreme Court of the United States · 1983
  5. Blue Chip Stamps v. Manor Drug StoresSupreme Court of the United States · 1975

111 more not listed; retrieve them via the Exa API.

3Cited by67 opinions

  1. Joblove v. Barr Labs. Inc.Court of Appeals for the Second Circuit · 2005
  2. In re Cardizem CD Antitrust LitigationDistrict Court, E.D. Michigan · 2003
  3. In Re K-Dur Antitrust LitigationDistrict Court, D. New Jersey · 2004
  4. In Re: Cardizem Cd Antitrust Litigation. Louisiana Wholesale Drug Co. v. Hoechst Marion Roussel, Inc., and Andrx Pharmaceuticals, Inc.Court of Appeals for the Sixth Circuit · 2003
  5. Andrx Pharmaceuticals, Inc. v. Biovail Corp. InternationalCourt of Appeals for the D.C. Circuit · 2001

62 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API